[1]
|
Newburger, J.W., Takahashi, M., Gerber, M.A., et al. (2004) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics, 114, 1708-1733. https://doi.org/10.1542/peds.2004-2182
|
[2]
|
林瑶, 李晓慧, 石林, 等. 2017版《川崎病的诊断、治疗及远期管理——美国心脏病协会对医疗专业人员的科学声明》解读[J]. 中国实用儿科杂志, 2017, 32(9): 641-648.
|
[3]
|
Sudo, D., Monobe, Y., Yashiro, M., Mieno, M.N., Uehara, R., Tsuchiya, K., Sonobe, T. and Nakamura, Y. (2012) Coronary Artery Lesions of Incomplete Kawasaki Disease: A Nationwide Survey in Japan. European Journal of Pediatrics, 171, 651-656. https://doi.org/10.1007/s00431-011-1630-3
|
[4]
|
Kim, G.B. (2019) Reality of Kawasaki Disease Epidemiology. Korean Journal of Pediatrics, 62, 292-296.
https://doi.org/10.3345/kjp.2019.00157
|
[5]
|
Rowley, A.H. and Shulman, S.T. (2018) The Epidemiology and Pathogensis of Kawasaki Disease. Frontiers in Pediatrics, 6, 374. https://doi.org/10.3389/fped.2018.00374
|
[6]
|
Kil, H.R., Yu, I.W., Lee, S.C., Rhim, J.W. and Lee, K.Y. (2017) Changes in Clinical and Laboratory Features of Kawasaki Disease Noted over Time in Daejeon, Korea. Pediatric Rheumatology Online Journal, 15, 60.
https://doi.org/10.1186/s12969-017-0192-y
|
[7]
|
Xie, L.P., Yan, W.L., Huang, M., et al. (2020) Epidemiologic Features of Kawasaki Disease in Shanghai from 2013 through 2017. Journal of Epidemiology, 30, 429-435.
|
[8]
|
Yeom, J.S., Woo, H.O., Park, J.S., et al. (2013) Kawasaki Disease. Korean Journal of Pediatrics, 56, 377-382.
https://doi.org/10.3345/kjp.2013.56.9.377
|
[9]
|
Advani, N., Santoso, L.A. and Sastroasmoro, S. (2019) Profile of Kawasaki Disease in Adolescents: Is It Different? Acta Medica Indonesiana, 51, 42-46.
|
[10]
|
Gomard-Mennesson, E., Landron, C., Dauphin, C., et al. (2010) Kawasaki Disease in Adults: Report of 10 Cases. Medicine (Baltimore), 89, 149-158. https://doi.org/10.1097/MD.0b013e3181df193c
|
[11]
|
金向群, 刘玭, 张秋萍. 不完全川崎病患儿遗传易感性研究[J]. 中国当代儿科杂志, 2015, 17(7): 663-667.
|
[12]
|
花旺, 龚方戚. 不完全型川崎病临床特征[J]. 中国实用儿科杂志, 2017, 38(8): 572-575.
|
[13]
|
Manlhiot, C., Christie, E., McCrindle, B.W., et al. (2012) Complete and Incomplete Kawasaki Disease: Two Sides of the Same Coin. European Journal of Pediatrics, 171, 657-662. https://doi.org/10.1007/s00431-011-1631-2
|
[14]
|
刘慧, 鲁姗, 邢燕, 等. 2007年至2016年单中心川崎病临床特征及变化趋势分析[J]. 中华实用儿科临床杂志, 2018, 33(21): 1627-1630.
|
[15]
|
王秀英, 董海云, 许毅, 刘东海. 88例不完全川崎病的临床特点及随访分析[J]. 中国当代儿科杂志, 2011, 13(1): 57-59.
|
[16]
|
刘远威, 段晨敏, 胡文明, 等. 儿童不完全川崎病70例临床分析[J]. 医学理论与实践, 2020, 33(3): 514-515.
|
[17]
|
Peng, C., Luo, Y.J., Xing, Q.L. and Xiao, M.C. (2016) Clinical Features of Children with Incomplete Kawasaki Disease. Chinese Journal of Contemporary Pediatrics, 18, 1111-1114.
|
[18]
|
刘波, 张久贵, 蒋鸿萍, 等. 不完全川崎病(IKD)患儿的临床特点分析[J]. 当代医学, 2020, 26(3): 52-54.
|
[19]
|
Fukushige, J., Takahashi, N., Ueda, Y., et al. (1994) Incidence and Clinical Features of Incomplete Kawasaki Disease. Acta Paediatrica, 83, 1057-1060. https://doi.org/10.1111/j.1651-2227.1994.tb12985.x
|
[20]
|
Loh, A.C.E., Kua, P.H.J. and Tan, Z.L. (2019) Erythema and Induration of the Bacillus Calmette-Guerin Site for Diagnosing Kawasaki Disease. Singapore Medical Journal, 60, 89-93. https://doi.org/10.11622/smedj.2018084
|
[21]
|
McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
|
[22]
|
Aljishi, F.M., Alsinan, A., Almadan, B., Almokhtar, R. and Alsinan, T. (2018) Diagnosing Incomplete Kawasaki Disease. Saudi Journal of Medicine & Medical Sciences, 6, 172-173. https://doi.org/10.4103/sjmms.sjmms_166_17
|
[23]
|
Kwon, H., Lee, J.H., Jung, J.Y., Kwak, Y.H., Kim, D.K., Jung, J.H., et al. (2016) N-Terminal Pro-Brain Natriuretic Peptide Can Be an Adjunctive Diagnostic Marker of Hyper-Acute Phase of Kawasaki Disease. European Journal of Pediatrics, 175, 1997-2003. https://doi.org/10.1007/s00431-016-2798-3
|
[24]
|
Mastrangelo, G., Cimaz, R., Calabri, G.B., Simonini, G., Lasagni, D., Resti, M. and Trapani, S. (2019) Kawasaki Disease in Infants Less than One Year of Age: An Italian Cohort from a Single Center. BMC Pediatrics, 19, 321.
https://doi.org/10.1186/s12887-019-1695-0
|
[25]
|
Arora, K., Guleria, S., Jindal, A.K., Rawat, A. and Singh, S. (2019) Platelets in Kawasaki Disease: Is This Only a Numbers Game or Something Beyond? Genes & Diseases, 7, 62-66. https://doi.org/10.1016/j.gendis.2019.09.003
|
[26]
|
Yellen, E.S., Gauvreau, K., Takahashi, M., et al. (2010) Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease. Pediatrics, 125, e234-e241. https://doi.org/10.1542/peds.2009-0606
|
[27]
|
Nomura, Y., Yashiro, M., Masuda, K. and Nakamura, Y. (2020) Treatment Change and Coronary Artery Abnormality in Incomplete Kawasaki Disease. Pediatrics International, 62, 779-784. https://doi.org/10.1111/ped.14242
|